PCOS Acne: Why It Happens and How to Treat the Root Cause

If you have PCOS and persistent acne, you’ve probably already done the rounds: cleansers, topicals, antibiotics, maybe even a dermatologist who handed you a prescription without asking a single question about your hormones. And if you’re reading this, those approaches probably didn’t fully work, or they worked temporarily and the acne came back the moment you stopped.

That pattern isn’t a coincidence. PCOS acne isn’t a skincare problem. It’s a hormone problem that shows up on your skin, and treating the skin alone without addressing what’s driving it from the inside is why so many women with PCOS cycle through treatments without finding lasting improvement.

How Common Is Acne in PCOS?

Acne is one of the most consistently documented manifestations of PCOS, with research estimating it affects between 40 and 70 percent of women with the condition, roughly two to three times the prevalence seen in women without PCOS. (Source: PubMed, PMC12747725) It tends to be more severe, more persistent, and more resistant to standard treatments than non-hormonal acne, and it frequently continues well into adulthood when most women without PCOS have long since stopped dealing with significant breakouts.

The severity tends to track with the degree of androgen excess, which is why women with more pronounced PCOS features, particularly those with both hyperandrogenism and insulin resistance, often have the most stubborn acne presentations. Understanding why requires looking at what’s actually happening biologically.

The Hormonal Mechanism Behind PCOS Acne

Androgens, particularly testosterone and its more potent derivative dihydrotestosterone (DHT), are the primary hormonal drivers of PCOS acne. They work by binding directly to androgen receptors on the sebaceous glands in your skin and triggering overproduction of sebum, your skin’s natural oil. (Source: PubMed, PMC5015761) That excess sebum creates two problems simultaneously: it blocks pores by mixing with dead skin cells to form plugs, and it creates an oxygen-poor, oil-rich environment where Cutibacterium acnes bacteria thrives.

Androgens also cause abnormal follicular keratinization, meaning the process by which dead skin cells shed from inside the pore is disrupted. Instead of sloughing off normally, those cells accumulate, contributing further to blockage. When blocked pores become colonized by bacteria and the immune system responds with inflammation, the result is the deep, painful cystic breakouts that characterize PCOS acne at its worst.

This is a four-part cycle: elevated androgens, excess sebum, bacterial overgrowth, and inflammation. Topical treatments address the bacterial and surface-level aspects of this cycle. They don’t reach the androgen signaling that started it.

The Insulin Resistance Amplifier

The androgen piece of PCOS acne doesn’t operate in isolation. Insulin resistance, present in the majority of women with PCOS, directly amplifies it through two mechanisms.

First, elevated insulin acts directly on the ovaries to stimulate androgen production. When insulin is chronically high due to poor cellular sensitivity, it acts like a co-stimulator for testosterone production, pushing androgen levels higher than they’d be from PCOS alone. Second, high insulin raises levels of insulin-like growth factor 1 (IGF-1), which independently stimulates androgen synthesis in both the ovaries and adrenal glands, and which also amplifies sebaceous gland activity directly. (Source: PubMed, PMC12223598)

Research has found a direct correlation between glucose levels and acne severity in women with PCOS, meaning that the more dysregulated the blood sugar, the worse the acne tends to be. This connection is clinically significant because it means that improving insulin sensitivity can reduce androgen-driven sebum production without ever directly touching androgen levels, by removing one of the key inputs driving the androgen excess in the first place.

Where PCOS Acne Appears and Why

Location is one of the clearest distinguishing features of hormonally-driven acne. PCOS acne has a characteristic distribution: the lower third of the face, specifically the jawline, chin, and lower cheeks, as well as the upper neck. It can also appear on the chest and upper back in more severe presentations.

This isn’t random. Sebaceous glands are most concentrated in these areas, and androgen receptors in the skin are more densely expressed along the jawline and chin in particular. A pattern of persistent, deep breakouts concentrated in this lower facial zone in an adult woman is a strong enough clinical signal that guidelines recommend considering androgen excess and PCOS screening, especially when the acne occurs alongside other features like irregular cycles, excess hair growth, or scalp thinning. (Source: PubMed)

How PCOS Acne Differs From Regular Hormonal Acne

Why Standard Treatments Often Fail

Topical retinoids, benzoyl peroxide, salicylic acid, and oral antibiotics all have legitimate places in acne management. What they don’t do is reduce androgen levels or improve insulin sensitivity. When those underlying drivers remain active, stopping any of these treatments typically results in the acne returning, sometimes rapidly.

This is the pattern I see described constantly by women with PCOS who’ve cycled through multiple dermatology appointments: something works while they’re using it and returns when they stop, without anyone ever addressing why it keeps coming back. The answer is almost always the same, the hormonal root cause wasn’t part of the treatment plan.

An important research note: a meaningful number of women with PCOS acne do not have elevated circulating testosterone on a standard lab panel. This doesn’t mean androgens aren’t the driver. Local skin androgen activity can be elevated even when blood levels appear normal, and alternative androgen pathways, particularly adrenal androgens like DHEA-S, are frequently involved in PCOS acne presentations even when testosterone specifically is within range. Treating a woman’s acne as non-hormonal because one hormone marker is normal is a common clinical miss.

Conventional Treatment Options

For PCOS acne specifically, conventional treatment goes further than topicals. The main medical options, all of which work at the hormonal level:

• Combined oral contraceptives: The most commonly prescribed first-line hormonal treatment for PCOS acne. They work by suppressing ovarian androgen production and increasing sex hormone-binding globulin (SHBG), which binds free testosterone and makes it less bioavailable. The progestin component matters significantly, since some progestins have androgenic activity of their own and can worsen acne rather than improve it.
• Spironolactone: An androgen receptor blocker that reduces the ability of androgens to stimulate sebaceous glands even when circulating levels haven’t changed. Commonly used alongside oral contraceptives in moderate to severe presentations that don’t respond adequately to contraceptives alone.
• Metformin: Primarily an insulin sensitizer, and its mechanism of action on PCOS acne works through that pathway, reducing the insulin-driven androgen stimulation described above. Some women with PCOS acne driven primarily by insulin resistance see meaningful improvement with metformin even without directly targeting androgens.
• Oral isotretinoin: Reserved for severe, refractory cases due to its side effect profile and the monitoring it requires. It addresses the sebaceous gland overactivity directly but doesn’t resolve the underlying androgen excess, which is why PCOS acne can recur after a course of isotretinoin.

Addressing the Root Cause: The Functional Nutrition Approach

From a functional standpoint, the most durable path to improving PCOS acne is improving the underlying hormonal environment rather than suppressing symptoms indefinitely. This means two things primarily: reducing insulin resistance and reducing the inflammatory burden that amplifies the androgen-sebum cycle.

The insulin sensitivity work I covered in the PCOS weight management context applies directly here. Improving cellular insulin response reduces the insulin-driven androgen stimulation that is one of the two primary inputs driving the acne. Dietary patterns that reduce glycemic load and blood sugar variability, adequate protein and fiber at meals, consistent meal timing, and resistance training as a metabolic intervention all contribute to this through the same mechanisms that benefit PCOS broadly.

Anti-inflammatory nutrition is particularly relevant to acne specifically because inflammation is the step in the cycle that converts a blocked pore into a painful, cystic lesion. The severity of an inflammatory response to the same bacterial colonization varies enormously between individuals, and chronic gut inflammation has been specifically identified as a contributor to the systemic inflammatory environment that makes PCOS acne worse. Working with a PCOS nutritionist who assesses gut health alongside hormones is a meaningfully different level of care than seeing someone who focuses only on the hormonal picture in isolation.

Nutraceuticals With Actual Evidence

A 2024 systematic review examining nutraceutical supplementation specifically for PCOS acne identified several compounds with meaningful evidence from randomized controlled trials. The review covered chromium, berberine, selenium, magnesium, and antioxidant combinations.

Berberine demonstrated significant reductions in acne severity alongside reductions in inflammatory markers including C-reactive protein. Chromium supplementation also showed measurable improvements in acne severity and inflammatory markers. Both of these work primarily through insulin sensitization rather than directly targeting androgens, which is consistent with the insulin-androgen mechanism described above. (Source: Journal of Integrative Dermatology)

Myo-inositol, which I covered in the PCOS weight management context for its insulin-sensitizing effects, also appears in the PCOS acne research. Its benefit for acne comes through the same pathway: improving cellular insulin signaling reduces the hyperinsulinemia that drives androgen production.

Zinc, Copper, and Androgen Metabolism

Zinc is one of the most studied minerals in acne research, and its relevance to PCOS acne is particularly direct. Zinc inhibits 5-alpha reductase, the enzyme that converts testosterone into the more potent DHT that binds most aggressively to sebaceous gland receptors. Zinc deficiency, therefore, can amplify androgen-driven sebum production even when androgen levels themselves haven’t changed.

In PCOS specifically, zinc deficiency is more common than in the general population, likely connected to the chronic inflammation and the metabolic disruption that characterizes the condition. Correcting a genuine zinc deficiency can meaningfully reduce the androgen-to-DHT conversion and the resulting sebaceous gland stimulation, which is why zinc has shown efficacy in acne research across multiple studies.

The copper side of this matters too. Copper excess and zinc deficiency often travel together, since the two minerals compete for absorption and balance each other in the body. Elevated copper contributes to inflammation and to the hormonal dysregulation I see consistently in the PCOS presentations where acne is most severe. Testing both minerals together, rather than assuming zinc supplementation alone is the answer, gives a more complete picture of what the mineral environment actually looks like.

What Testing Tells You That Standard Labs Miss

A standard hormonal panel from a GP might include total testosterone and LH. For PCOS acne specifically, that’s rarely enough. Free testosterone, DHEA-S, SHBG, and fasting insulin together give a more complete picture of which androgen sources are elevated and how much the insulin-androgen amplification is contributing.

A DUTCH hormone test goes further by showing not just circulating hormone levels but the full metabolic pathway, including which androgens are being produced in excess, how efficiently testosterone is being cleared, and whether the 5-alpha reductase pathway (which produces DHT from testosterone) is overactive. It also includes cortisol markers, which matter for identifying adrenal androgen contributions to the picture.

This level of detail is why two women with PCOS acne who look similar on a basic panel can respond very differently to the same treatment. The androgen source, the metabolic pathway, and the degree of insulin resistance are all individual variables that a more complete assessment identifies.

Frequently Asked Questions

This article is for educational purposes and is not a substitute for professional medical advice. PCOS acne can range from mild to severe, and appropriate treatment depends on your specific hormonal profile and medical history. Please work with a qualified healthcare provider or functional nutrition counselor for personalized evaluation and guidance.